Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > ACLARA Signs GlaxoSmithKline to eTag™ Access Agreement

July 30th, 2003

ACLARA Signs GlaxoSmithKline to eTag™ Access Agreement

Abstract:
ACLARA BioSciences announced today that it has entered into an eTag™ Access Agreement with GlaxoSmithKline (GSK), under which GSK will gain access to ACLARA's proprietary eTag Assay System for use in its biopharmaceutical research and development activities.

Source:
ACLARA

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026

COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026

Breathing new life into nanotubes for a cooler planet:Researchers at Skoltech discover a simple, single-step heat treatment that nearly doubles the CO2-trapping power of carbon nanotubes January 30th, 2026

New light-based nanotechnology could enable more precise, less harmful cancer treatment: The approach offers a potential alternative to chemotherapy and radiation by using light and heat to target cancer cells. January 30th, 2026

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books



NNN
The Hunger Project